Covered recipient · General Payments record
ZAINAB IQBAL MIAN
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$1,330.26
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $420.35 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $88.87 | 5 |
| Corcept Therapeutics | $77.86 | 4 |
| Insulet Corporation | $76.87 | 4 |
| Lilly USA, LLC | $71.03 | 4 |
| Abbott Laboratories | $44.37 | 2 |
| Xeris Pharmaceuticals, Inc. | $21.27 | 1 |
| Amgen Inc. | $20.26 | 1 |
| Medtronic, Inc. | $19.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.22 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125273645 | CMS |
| Abbott Laboratories | $20.15 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125273647 | CMS |
| Amgen Inc. | $20.26 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115930295 | CMS |
| Corcept Therapeutics | $21.67 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117761211 | CMS |
| Corcept Therapeutics | $17.75 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117761321 | CMS |
| Corcept Therapeutics | $14.50 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117761325 | CMS |
| Corcept Therapeutics | $23.94 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117761339 | CMS |
| Insulet Corporation | $21.10 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116800226 | CMS |
| Insulet Corporation | $22.58 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116800224 | CMS |
| Insulet Corporation | $13.44 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116810053 | CMS |
| Insulet Corporation | $19.75 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116810051 | CMS |
| Lilly USA, LLC | $19.87 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135477730 | CMS |
| Lilly USA, LLC | $23.09 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135507122 | CMS |
| Lilly USA, LLC | $14.52 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135456505 | CMS |
| Lilly USA, LLC | $13.55 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135443321 | CMS |
| Medtronic, Inc. | $19.82 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119486336 | CMS |
| Novo Nordisk Inc | $19.29 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097335547 | CMS |
| Novo Nordisk Inc | $15.34 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096791191 | CMS |
| Novo Nordisk Inc | $21.32 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097127880 | CMS |
| Novo Nordisk Inc | $16.78 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097707190 | CMS |
| Novo Nordisk Inc | $16.14 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097427866 | CMS |
| Xeris Pharmaceuticals, Inc. | $21.27 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144618189 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.